Varices are abnormally swollen, thin-walled veins that develop when blood pressure builds up in the portal venous system, the network of vessels that carries blood from the digestive organs through the liver. They most commonly appear in the esophagus and stomach, though they can form in surprising locations throughout the body. The danger is straightforward: these distended veins can rupture and bleed massively, with a six-week mortality rate of roughly 10 to 20 percent even with modern treatment.1PubMed. Management of acute variceal bleeding: updated APASL guidelines Understanding how they form, who is at risk, and what can be done about them matters because the window between “present but stable” and “life-threatening emergency” can close quickly.
How Varices Form
The root cause is portal hypertension, a sustained increase in blood pressure within the portal vein. In a healthy liver, blood flows through tiny channels called sinusoids with relatively low resistance. When the liver becomes scarred from chronic disease, those channels narrow and stiffen, forcing blood to back up. The body, looking for alternate routes, reroutes blood through smaller veins that were never designed to handle that volume or pressure. These veins balloon outward, becoming varices.2PubMed Central. Pathophysiology of portal hypertension
The pressure gradient that matters is the difference between the portal vein and the rest of the venous system. Normally that gap is below 5 mmHg. Once it crosses about 10 mmHg, the risk of developing varices climbs sharply. Above 12 mmHg, bleeding becomes a real threat.3Clinical and Molecular Hepatology. Hepatic venous pressure gradient: clinical use in chronic liver disease This pressure gradient is measured using a procedure called the hepatic venous pressure gradient, considered the gold standard for assessing portal hypertension.4PubMed Central. Hepatic venous-portal gradient (HVPG) measurement: pearls and pitfalls
Cirrhosis from any cause is the leading driver, but it is not the only one. Portal vein thrombosis, a blood clot in the portal vein itself, can cause significant portal hypertension even in people whose livers are otherwise healthy. In chronic cases, the collateral veins that develop around the clot can themselves become varices, putting the patient at risk for bleeding and fluid buildup in the abdomen.5PubMed Central. Portal Vein Thrombosis in Patients Without Cirrhosis: Current Practical Approaches and Treatment Strategies The formation of these new blood vessel pathways is driven by angiogenesis, a process involving specific liver cells that actively build collateral channels in response to the elevated pressure.6PubMed. Angiogenesis and portal-systemic collaterals in portal hypertension
Where Varices Show Up
The esophagus is the most familiar location. Veins in the lower esophagus sit close to the surface of the lining, and when they expand under pressure, they bulge into the hollow tube where food passes. This is the spot where rupture is most common and most dangerous.
Gastric varices, those in the stomach, are a different challenge. A landmark study classifying gastric varices in over 500 patients with portal hypertension found that the most common type runs along the lesser curvature of the stomach and tends to behave like an extension of esophageal varices. But isolated fundal varices, those sitting at the top of the stomach, bled in about 78 percent of cases and carried high mortality. Varices extending along the greater curvature of the stomach also bled frequently, at around 55 percent.7PubMed. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients Gastric varices are generally harder to treat endoscopically than esophageal ones, which is part of what makes them so worrisome.
Then there are ectopic varices, which appear in places most people would not expect. A study of patients with portal hypertension found ectopic varices in the rectum, duodenum, small intestine, bladder, colon, and even at surgical stoma sites.8PubMed Central. Clinicopathological features and treatment of ectopic varices with portal hypertension The symptoms depend entirely on where they are. Duodenal varices can cause vomiting blood or dark stool. Bladder varices show up as blood in the urine. Varices near the diaphragm have caused bleeding into the chest cavity, and abdominal wall varices can rupture into the peritoneal cavity, causing hidden internal hemorrhage that is hard to diagnose quickly.9Gastrointestinal Intervention. Diagnosis and management of ectopic varices These ectopic cases are uncommon, but they underscore why unexplained bleeding in a patient with known liver disease should always raise the question of varices in unexpected locations.
What Makes Them Rupture
A varix does not simply pop at random. The risk of rupture is governed by the tension on its wall, which depends on the pressure inside, the size of the vein, and the thickness of the tissue covering it. As a varix grows larger, its wall stretches thinner, and the same internal pressure produces far more tension on that thinned tissue. This is why larger varices are more dangerous than smaller ones, even at comparable portal pressures.
Ascites, the accumulation of fluid in the abdomen common in advanced liver disease, makes things worse. Patients with ascites have been shown to have higher variceal wall tension than those without it.10PubMed. Patients with ascites have higher variceal pressure and wall tension than patients without ascites One study in cirrhotic patients found that draining the abdominal fluid reduced the pressure inside varices by about 30 percent and cut wall tension by roughly 60 percent.11PubMed. Total volume paracentesis decreases variceal pressure, size, and variceal wall tension in cirrhotic patients This connection between ascites and variceal bleeding is one reason why managing fluid buildup is not just about comfort but about preventing catastrophic hemorrhage.
Endoscopic signs also help predict which varices are likely to bleed soon. Red color signs on the variceal surface, particularly hematocystic spots (small blood blisters on the vein wall), are strong indicators of impending rupture. A retrospective analysis found that even in small, straight esophageal varices, the presence of hematocystic spots was a significant predictor of early bleeding.12PubMed Central. The Risk of Bleeding in Small/Straight Esophageal Varices with Red Color Sign on Endoscopy: A Retrospective Analysis from the Natural Course In practical terms, a gastroenterologist looking through an endoscope uses the varix size, the presence of these red marks, and the severity of the underlying liver disease together to gauge bleeding risk.
How Dangerous a Bleed Really Is
A ruptured varix can produce rapid, high-volume blood loss. Because the bleeding is internal, into the esophagus or stomach, it often presents as vomiting large amounts of blood or passing dark, tarry stool. This is a medical emergency requiring immediate hospitalization. The mortality from a single variceal bleeding episode has dropped significantly over the past two decades thanks to better treatments, falling from about 40 percent to roughly 15 to 20 percent.13PubMed. Acute variceal bleeding That is a remarkable improvement, but a one-in-five chance of dying from a single bleed still makes this one of the most dangerous complications in gastroenterology.
The risk is highest in patients who already have decompensated liver disease, meaning their liver has lost the ability to compensate for its damage. In patients with ascites or hepatic encephalopathy (confusion caused by toxin buildup from liver failure), acute variceal bleeding carries an especially high mortality rate.14PubMed Central. Management of acute variceal bleeding Even among those who survive the first bleed, 10 to 20 percent fail to stop bleeding initially or rebleed within the first five days.13PubMed. Acute variceal bleeding
Screening and Catching Varices Before They Bleed
Because varices produce no symptoms until they rupture, screening is essential in anyone with chronic liver disease. The standard approach is an upper endoscopy, where a flexible camera is passed through the mouth into the esophagus and stomach to look directly at the veins.15PubMed Central. Diagnosis and Management of Esophagogastric Varices This lets the doctor assess varix size, look for red color signs, and decide whether preventive treatment is needed.
Endoscopy is effective but invasive, and not everyone with liver disease actually has high-risk varices. Guidelines known as the Baveno criteria try to spare low-risk patients from unnecessary procedures. The approach combines liver stiffness measurement (an ultrasound-based test) with a platelet count from a standard blood draw. If liver stiffness is below 20 kPa and platelet count is above 150,000 per microliter, the patient can safely skip endoscopy because the risk of having dangerous varices is very low.16PubMed Central. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices Newer versions of these criteria, including spleen stiffness measurements, can spare even more patients from endoscopy while still catching most high-risk cases.17Journal of Hepatology. Validation of the Baveno VII algorithm and spleen stiffness measurement in HBV-related cirrhosis
The thresholds are not one-size-fits-all, though. Research in patients with cirrhosis from fatty liver disease found that adjusted cutoffs, using a lower platelet threshold and higher stiffness threshold, could reduce the number of endoscopies performed by about a third more than the standard Baveno criteria without missing dangerous varices.18PubMed. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis The trend in the field is toward tailoring the screening algorithm to the specific cause of liver disease, not treating every patient identically.
Preventing the First Bleed
Once varices are found, the goal shifts to making sure they never rupture. Two main tools exist for this: medication and endoscopic treatment. The medications are non-selective beta-blockers, drugs like propranolol and nadolol that lower portal pressure by reducing heart output and constricting the blood vessels feeding the portal system. Endoscopic variceal band ligation involves placing tiny rubber bands around each varix during endoscopy, strangling the blood supply until the vein shrivels.
Which approach is better for first-time prevention has been debated extensively. A meta-analysis comparing beta-blockers to band ligation found that ligation appeared to have lower overall bleeding rates, but when only high-quality trials were considered, the difference vanished. Neither approach showed a clear survival advantage over the other, and the authors concluded that current evidence is insufficient to recommend ligation over beta-blockers as the first choice.19Annals of Hepatology. Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding A randomized trial directly comparing the two found essentially identical bleeding rates, around 16 to 19 percent at two years, with comparable bleeding-related deaths.20Gastroenterology. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis
In practice, many centers start with beta-blockers because they are inexpensive, taken as pills, and do not require repeated endoscopies. Band ligation is often reserved for patients who cannot tolerate the medication or whose varices look particularly threatening.
After a Bleed Has Already Happened
Surviving a first variceal bleed changes the calculus. Without further treatment, rebleeding is common and often fatal. For secondary prevention, the combination of beta-blockers and band ligation is now the standard recommendation.21PubMed Central. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis Using both approaches together covers two different angles: the medication lowers the driving pressure, while the ligation physically eliminates the enlarged veins.
For gastric varices specifically, a study looking at endoscopic treatment found that adding beta-blockers to the endoscopic therapy reduced the five-year rebleeding rate from about 46 percent to 31 percent.22PubMed Central. Secondary Prophylaxis of Cirrhotic Gastric Variceal Bleeding: Addition of Non-Selective Beta-Blockers to Endoscopic Combined Treatment Five-year survival did not differ significantly between groups, suggesting the beta-blockers helped prevent rebleeds without clearly extending life on their own in this population.
A network meta-analysis comparing all the major strategies for secondary prevention found that TIPS, a procedure that creates an artificial channel inside the liver to relieve portal pressure, ranked highest for preventing rebleeding. However, TIPS did not translate that advantage into better overall survival compared to other approaches.23PubMed. Comparison of Therapies for Secondary Prophylaxis of Esophageal Variceal Bleeding in Cirrhosis: A Network Meta-analysis of Randomized Controlled Trials Carvedilol, a specific beta-blocker, ranked first for survival in that analysis, though the differences between treatments were not statistically significant. The takeaway is that the tools for preventing a second bleed are good but imperfect, and the choice often depends on the individual patient’s liver function and tolerance of each therapy.
When Bleeding Will Not Stop
In an active variceal bleed, the first-line response combines vasoactive drugs, medications like terlipressin or octreotide that constrict the blood vessels feeding the portal system, with emergency endoscopy to band or inject the bleeding varix.24Journal of Pharmaceutical Research International. Efficacy of Octreotide Versus Terlipressin along with Endoscopic Variceal Ligation (EVL) in Preventing Re-bleeding and Mortality in Acute Bleeding Esophageal Varices in Cirrhosis: A Randomized Prospective Study This combination stops the bleeding in most patients.
For the fraction who keep bleeding despite these measures, TIPS becomes a salvage option. The procedure threads a catheter through the jugular vein in the neck, down into the liver, and creates a shunt between the portal vein and the hepatic vein, immediately dropping the portal pressure. As a salvage tool, TIPS is effective at controlling hemorrhage, but the outcomes are grim: about one-third of patients with refractory bleeding who receive salvage TIPS die within six weeks.25PubMed Central. Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta‐analysis That high mortality reflects the severity of the underlying liver disease in these patients rather than a failure of the procedure itself.
There is growing interest in using TIPS earlier, before bleeding becomes refractory, in patients judged to be at high risk. This “preemptive TIPS” approach may improve survival by intervening before the situation deteriorates to the point where salvage is needed.26Current Hepatology Reports. Role of Tips in Acute Variceal Bleeding
Varices in Children
Most discussions of varices focus on adults with cirrhosis, but children can develop them too, sometimes before their second birthday. Biliary atresia, a condition where the bile ducts fail to form properly in infants, is one of the leading causes. A prospective study of 139 children with biliary atresia found that 88 of 125 who underwent endoscopy already had esophageal varices, including 74 children under the age of two. Twenty-eight children experienced gastrointestinal bleeding at a median age of 17 months. The strongest predictors of bleeding were gastric varices along the cardia and red markings on the variceal wall, and spontaneous regression of the varices was rare.27PubMed. Prognostic value of endoscopy in children with biliary atresia at risk for early development of varices and bleeding
A separate study confirmed that high-grade esophageal varices, red color signs, and low fibrinogen levels at the first endoscopy were the most significant predictors of bleeding in children with biliary atresia. About 20 percent of patients in that series experienced gastrointestinal bleeding, with some as young as six months old.28PubMed. Assessment of risk of bleeding from esophageal varices during management of biliary atresia in children The general principles of management, screening endoscopy and preventive treatment when high-risk features are found, apply in pediatric patients, though the technical challenges of performing endoscopy and band ligation in very small children are considerable.
The Gut-Liver Connection
Research into what happens at the microscopic level in portal hypertension has uncovered an unexpected player: gut bacteria. As portal pressure rises, the intestinal barrier becomes leakier, allowing bacteria to cross from the gut into the bloodstream. A study examining the circulating microbiome in patients with cirrhosis found distinct bacterial profiles in their blood, with certain genera enriched in patients who had severe portal hypertension. While these microbial signatures were associated with disease severity and inflammation markers, they could not reliably predict how severe the portal hypertension was in individual patients.29PubMed Central. Circulating microbiome in patients with portal hypertension
This gut-liver axis is an active area of investigation. The bacterial translocation that comes with portal hypertension contributes to systemic inflammation, which in turn worsens liver function and drives the pressure gradient higher, creating a vicious cycle. Whether targeting the gut microbiome could eventually become a way to lower portal pressure or reduce variceal risk remains an open question, but it illustrates how varices are not just a plumbing problem. They sit at the intersection of liver disease, vascular remodeling, immune activation, and microbial ecology.
Living with Varices
For patients who know they have varices but have not yet bled, the experience is a mix of medical surveillance and anxiety. Regular endoscopies, daily beta-blocker pills with their side effects of fatigue and low blood pressure, and the awareness that a catastrophic bleed could happen at any time all take a psychological toll. A randomized study of patients with liver cirrhosis found that higher disease severity scores were the strongest predictor of worse health-related quality of life, with patients reporting significant burdens in fatigue, emotional function, and worry.30PubMed Central. Health-related Quality of Life in Patients With Liver Cirrhosis: A Randomized Study – Section: Results Patients with compensated cirrhosis, where the liver is still functioning reasonably well, showed improvements in symptoms and emotional well-being during follow-up, while those with decompensated disease improved in different domains like activity level and emotional coping.
This distinction matters practically. If your liver disease is caught early and managed aggressively, the varices may remain small and stable for years, and your quality of life may not be dramatically different from someone without liver disease. If the disease progresses to decompensation, varices become just one piece of a much larger clinical picture that includes fluid retention, confusion, and declining liver function. At that point, the conversation often shifts from managing varices specifically to whether liver transplantation is an option, since a new liver is the only way to truly eliminate the portal hypertension driving the whole problem.